US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist
  • 8.930
  • +0.130+1.48%
Close Jul 22 16:00 ET
  • 8.930
  • 0.0000.00%
Post 16:22 ET
465.11MMarket Cap-4933P/E (TTM)

EyePoint Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EyePoint Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

11.68M

+52.08%
EPS(YoY)

-0.55

+1.79%
Analyst Rating

Strong Buy

Jul 22, 2024

EyePoint Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 9.259M--
--2024/Q2-- / 9.594M--
--2024/Q111.684M / 9.135M--
Mar 7, 20242023/Q414.028M / 8.703M--
Nov 1, 20232023/Q315.202M / 7.430M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 9.259M--
--2024/Q2-- / 9.594M--
--2024/Q111.684M / 9.135M--
Mar 7, 20242023/Q414.028M / 8.703M--
Nov 1, 20232023/Q315.202M / 7.430M--

Unlock Free Earnings Estimates

EyePoint Pharmaceuticals Earnings Reports

  • EyePoint Pharmaceuticals | 10-Q: Quarterly report

    May 9 10:17 ET

  • EyePoint Pharmaceuticals | 10-K: Annual report

    Mar 8 13:56 ET

  • EyePoint Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 15:47 ET

  • EyePoint Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 4, 2023 15:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg